Click for best price
Chronic Pain Management Drugs Market Size, Share 2023
This report contains market size and forecasts of Chronic Pain Management Drugs in Global, including the following market information:
Global Chronic Pain Management Drugs Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Chronic Pain Management Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Opioids Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Chronic Pain Management Drugs include Pfizer Inc., Depomed Inc., Endo International plc., Purdue Pharma L.P., Novartis AG, AstraZeneca plc., Johnson and Johnson Services Inc., Merck & Co. and Abbott Laboratories, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Chronic Pain Management Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Pain Management Drugs Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Chronic Pain Management Drugs Market Segment Percentages, by Type, 2022 (%)
Opioids
Non-narcotic Analgesic
Others
Global Chronic Pain Management Drugs Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Chronic Pain Management Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Chronic Pain Management Drugs Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Chronic Pain Management Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chronic Pain Management Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Chronic Pain Management Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer Inc.
Depomed Inc.
Endo International plc.
Purdue Pharma L.P.
Novartis AG
AstraZeneca plc.
Johnson and Johnson Services Inc.
Merck & Co.
Abbott Laboratories
GlaxoSmithKline plc.
Teva Pharmaceutical Industries Ltd.
| Report Attributes |
Report Details |
| Report Title |
Chronic Pain Management Drugs Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Chronic Pain Management Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chronic Pain Management Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chronic Pain Management Drugs Overall Market Size
2.1 Global Chronic Pain Management Drugs Market Size: 2022 VS 2030
2.2 Global Chronic Pain Management Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Chronic Pain Management Drugs Players in Global Market
3.2 Top Global Chronic Pain Management Drugs Companies Ranked by Revenue
3.3 Global Chronic Pain Management Drugs Revenue by Companies
3.4 Top 3 and Top 5 Chronic Pain Management Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Chronic Pain Management Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chronic Pain Management Drugs Players in Global Market
3.6.1 List of Global Tier 1 Chronic Pain Management Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Chronic Pain Management Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Chronic Pain Management Drugs Market Size Markets, 2022 & 2030
4.1.2 Opioids
4.1.3 Non-narcotic Analgesic
4.1.4 Others
4.2 By Type - Global Chronic Pain Management Drugs Revenue & Forecasts
4.2.1 By Type - Global Chronic Pain Management Drugs Revenue, 2018-2023
4.2.2 By Type - Global Chronic Pain Management Drugs Revenue, 2023-2030
4.2.3 By Type - Global Chronic Pain Management Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Chronic Pain Management Drugs Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Chronic Pain Management Drugs Revenue & Forecasts
5.2.1 By Application - Global Chronic Pain Management Drugs Revenue, 2018-2023
5.2.2 By Application - Global Chronic Pain Management Drugs Revenue, 2023-2030
5.2.3 By Application - Global Chronic Pain Management Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Chronic Pain Management Drugs Market Size, 2022 & 2030
6.2 By Region - Global Chronic Pain Management Drugs Revenue & Forecasts
6.2.1 By Region - Global Chronic Pain Management Drugs Revenue, 2018-2023
6.2.2 By Region - Global Chronic Pain Management Drugs Revenue, 2023-2030
6.2.3 By Region - Global Chronic Pain Management Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Chronic Pain Management Drugs Revenue, 2018-2030
6.3.2 US Chronic Pain Management Drugs Market Size, 2018-2030
6.3.3 Canada Chronic Pain Management Drugs Market Size, 2018-2030
6.3.4 Mexico Chronic Pain Management Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Chronic Pain Management Drugs Revenue, 2018-2030
6.4.2 Germany Chronic Pain Management Drugs Market Size, 2018-2030
6.4.3 France Chronic Pain Management Drugs Market Size, 2018-2030
6.4.4 U.K. Chronic Pain Management Drugs Market Size, 2018-2030
6.4.5 Italy Chronic Pain Management Drugs Market Size, 2018-2030
6.4.6 Russia Chronic Pain Management Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Chronic Pain Management Drugs Market Size, 2018-2030
6.4.8 Benelux Chronic Pain Management Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Chronic Pain Management Drugs Revenue, 2018-2030
6.5.2 China Chronic Pain Management Drugs Market Size, 2018-2030
6.5.3 Japan Chronic Pain Management Drugs Market Size, 2018-2030
6.5.4 South Korea Chronic Pain Management Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Chronic Pain Management Drugs Market Size, 2018-2030
6.5.6 India Chronic Pain Management Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Chronic Pain Management Drugs Revenue, 2018-2030
6.6.2 Brazil Chronic Pain Management Drugs Market Size, 2018-2030
6.6.3 Argentina Chronic Pain Management Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Chronic Pain Management Drugs Revenue, 2018-2030
6.7.2 Turkey Chronic Pain Management Drugs Market Size, 2018-2030
6.7.3 Israel Chronic Pain Management Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Chronic Pain Management Drugs Market Size, 2018-2030
6.7.5 UAE Chronic Pain Management Drugs Market Size, 2018-2030
7 Players Profiles
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Corporate Summary
7.1.2 Pfizer Inc. Business Overview
7.1.3 Pfizer Inc. Chronic Pain Management Drugs Major Product Offerings
7.1.4 Pfizer Inc. Chronic Pain Management Drugs Revenue in Global Market (2018-2023)
7.1.5 Pfizer Inc. Key News
7.2 Depomed Inc.
7.2.1 Depomed Inc. Corporate Summary
7.2.2 Depomed Inc. Business Overview
7.2.3 Depomed Inc. Chronic Pain Management Drugs Major Product Offerings
7.2.4 Depomed Inc. Chronic Pain Management Drugs Revenue in Global Market (2018-2023)
7.2.5 Depomed Inc. Key News
7.3 Endo International plc.
7.3.1 Endo International plc. Corporate Summary
7.3.2 Endo International plc. Business Overview
7.3.3 Endo International plc. Chronic Pain Management Drugs Major Product Offerings
7.3.4 Endo International plc. Chronic Pain Management Drugs Revenue in Global Market (2018-2023)
7.3.5 Endo International plc. Key News
7.4 Purdue Pharma L.P.
7.4.1 Purdue Pharma L.P. Corporate Summary
7.4.2 Purdue Pharma L.P. Business Overview
7.4.3 Purdue Pharma L.P. Chronic Pain Management Drugs Major Product Offerings
7.4.4 Purdue Pharma L.P. Chronic Pain Management Drugs Revenue in Global Market (2018-2023)
7.4.5 Purdue Pharma L.P. Key News
7.5 Novartis AG
7.5.1 Novartis AG Corporate Summary
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Chronic Pain Management Drugs Major Product Offerings
7.5.4 Novartis AG Chronic Pain Management Drugs Revenue in Global Market (2018-2023)
7.5.5 Novartis AG Key News
7.6 AstraZeneca plc.
7.6.1 AstraZeneca plc. Corporate Summary
7.6.2 AstraZeneca plc. Business Overview
7.6.3 AstraZeneca plc. Chronic Pain Management Drugs Major Product Offerings
7.6.4 AstraZeneca plc. Chronic Pain Management Drugs Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca plc. Key News
7.7 Johnson and Johnson Services Inc.
7.7.1 Johnson and Johnson Services Inc. Corporate Summary
7.7.2 Johnson and Johnson Services Inc. Business Overview
7.7.3 Johnson and Johnson Services Inc. Chronic Pain Management Drugs Major Product Offerings
7.7.4 Johnson and Johnson Services Inc. Chronic Pain Management Drugs Revenue in Global Market (2018-2023)
7.7.5 Johnson and Johnson Services Inc. Key News
7.8 Merck & Co.
7.8.1 Merck & Co. Corporate Summary
7.8.2 Merck & Co. Business Overview
7.8.3 Merck & Co. Chronic Pain Management Drugs Major Product Offerings
7.8.4 Merck & Co. Chronic Pain Management Drugs Revenue in Global Market (2018-2023)
7.8.5 Merck & Co. Key News
7.9 Abbott Laboratories
7.9.1 Abbott Laboratories Corporate Summary
7.9.2 Abbott Laboratories Business Overview
7.9.3 Abbott Laboratories Chronic Pain Management Drugs Major Product Offerings
7.9.4 Abbott Laboratories Chronic Pain Management Drugs Revenue in Global Market (2018-2023)
7.9.5 Abbott Laboratories Key News
7.10 GlaxoSmithKline plc.
7.10.1 GlaxoSmithKline plc. Corporate Summary
7.10.2 GlaxoSmithKline plc. Business Overview
7.10.3 GlaxoSmithKline plc. Chronic Pain Management Drugs Major Product Offerings
7.10.4 GlaxoSmithKline plc. Chronic Pain Management Drugs Revenue in Global Market (2018-2023)
7.10.5 GlaxoSmithKline plc. Key News
7.11 Teva Pharmaceutical Industries Ltd.
7.11.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
7.11.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.11.3 Teva Pharmaceutical Industries Ltd. Chronic Pain Management Drugs Major Product Offerings
7.11.4 Teva Pharmaceutical Industries Ltd. Chronic Pain Management Drugs Revenue in Global Market (2018-2023)
7.11.5 Teva Pharmaceutical Industries Ltd. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Chronic Pain Management Drugs Market Opportunities & Trends in Global Market
Table 2. Chronic Pain Management Drugs Market Drivers in Global Market
Table 3. Chronic Pain Management Drugs Market Restraints in Global Market
Table 4. Key Players of Chronic Pain Management Drugs in Global Market
Table 5. Top Chronic Pain Management Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Chronic Pain Management Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Chronic Pain Management Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Chronic Pain Management Drugs Product Type
Table 9. List of Global Tier 1 Chronic Pain Management Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Pain Management Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Chronic Pain Management Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Chronic Pain Management Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Chronic Pain Management Drugs Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Chronic Pain Management Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Chronic Pain Management Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Chronic Pain Management Drugs Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Chronic Pain Management Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Chronic Pain Management Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Chronic Pain Management Drugs Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Chronic Pain Management Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Chronic Pain Management Drugs Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Chronic Pain Management Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Chronic Pain Management Drugs Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Chronic Pain Management Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Chronic Pain Management Drugs Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Chronic Pain Management Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Chronic Pain Management Drugs Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Chronic Pain Management Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Chronic Pain Management Drugs Revenue, (US$, Mn), 2023-2030
Table 30. Pfizer Inc. Corporate Summary
Table 31. Pfizer Inc. Chronic Pain Management Drugs Product Offerings
Table 32. Pfizer Inc. Chronic Pain Management Drugs Revenue (US$, Mn), (2018-2023)
Table 33. Depomed Inc. Corporate Summary
Table 34. Depomed Inc. Chronic Pain Management Drugs Product Offerings
Table 35. Depomed Inc. Chronic Pain Management Drugs Revenue (US$, Mn), (2018-2023)
Table 36. Endo International plc. Corporate Summary
Table 37. Endo International plc. Chronic Pain Management Drugs Product Offerings
Table 38. Endo International plc. Chronic Pain Management Drugs Revenue (US$, Mn), (2018-2023)
Table 39. Purdue Pharma L.P. Corporate Summary
Table 40. Purdue Pharma L.P. Chronic Pain Management Drugs Product Offerings
Table 41. Purdue Pharma L.P. Chronic Pain Management Drugs Revenue (US$, Mn), (2018-2023)
Table 42. Novartis AG Corporate Summary
Table 43. Novartis AG Chronic Pain Management Drugs Product Offerings
Table 44. Novartis AG Chronic Pain Management Drugs Revenue (US$, Mn), (2018-2023)
Table 45. AstraZeneca plc. Corporate Summary
Table 46. AstraZeneca plc. Chronic Pain Management Drugs Product Offerings
Table 47. AstraZeneca plc. Chronic Pain Management Drugs Revenue (US$, Mn), (2018-2023)
Table 48. Johnson and Johnson Services Inc. Corporate Summary
Table 49. Johnson and Johnson Services Inc. Chronic Pain Management Drugs Product Offerings
Table 50. Johnson and Johnson Services Inc. Chronic Pain Management Drugs Revenue (US$, Mn), (2018-2023)
Table 51. Merck & Co. Corporate Summary
Table 52. Merck & Co. Chronic Pain Management Drugs Product Offerings
Table 53. Merck & Co. Chronic Pain Management Drugs Revenue (US$, Mn), (2018-2023)
Table 54. Abbott Laboratories Corporate Summary
Table 55. Abbott Laboratories Chronic Pain Management Drugs Product Offerings
Table 56. Abbott Laboratories Chronic Pain Management Drugs Revenue (US$, Mn), (2018-2023)
Table 57. GlaxoSmithKline plc. Corporate Summary
Table 58. GlaxoSmithKline plc. Chronic Pain Management Drugs Product Offerings
Table 59. GlaxoSmithKline plc. Chronic Pain Management Drugs Revenue (US$, Mn), (2018-2023)
Table 60. Teva Pharmaceutical Industries Ltd. Corporate Summary
Table 61. Teva Pharmaceutical Industries Ltd. Chronic Pain Management Drugs Product Offerings
Table 62. Teva Pharmaceutical Industries Ltd. Chronic Pain Management Drugs Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Chronic Pain Management Drugs Segment by Type in 2022
Figure 2. Chronic Pain Management Drugs Segment by Application in 2022
Figure 3. Global Chronic Pain Management Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Chronic Pain Management Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Chronic Pain Management Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Chronic Pain Management Drugs Revenue in 2022
Figure 8. By Type - Global Chronic Pain Management Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Chronic Pain Management Drugs Revenue Market Share, 2018-2030
Figure 10. By Region - Global Chronic Pain Management Drugs Revenue Market Share, 2018-2030
Figure 11. By Country - North America Chronic Pain Management Drugs Revenue Market Share, 2018-2030
Figure 12. US Chronic Pain Management Drugs Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Chronic Pain Management Drugs Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Chronic Pain Management Drugs Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Chronic Pain Management Drugs Revenue Market Share, 2018-2030
Figure 16. Germany Chronic Pain Management Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. France Chronic Pain Management Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Chronic Pain Management Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Chronic Pain Management Drugs Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Chronic Pain Management Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Chronic Pain Management Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Chronic Pain Management Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Chronic Pain Management Drugs Revenue Market Share, 2018-2030
Figure 24. China Chronic Pain Management Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Chronic Pain Management Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Chronic Pain Management Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Chronic Pain Management Drugs Revenue, (US$, Mn), 2018-2030
Figure 28. India Chronic Pain Management Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Chronic Pain Management Drugs Revenue Market Share, 2018-2030
Figure 30. Brazil Chronic Pain Management Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Chronic Pain Management Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Chronic Pain Management Drugs Revenue Market Share, 2018-2030
Figure 33. Turkey Chronic Pain Management Drugs Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Chronic Pain Management Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Chronic Pain Management Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Chronic Pain Management Drugs Revenue, (US$, Mn), 2018-2030
Figure 37. Pfizer Inc. Chronic Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Depomed Inc. Chronic Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Endo International plc. Chronic Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Purdue Pharma L.P. Chronic Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Novartis AG Chronic Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AstraZeneca plc. Chronic Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Johnson and Johnson Services Inc. Chronic Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck & Co. Chronic Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Abbott Laboratories Chronic Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. GlaxoSmithKline plc. Chronic Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Teva Pharmaceutical Industries Ltd. Chronic Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
